Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C O Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115466165B reveals a novel deep eutectic solvent method for synthesizing high-purity 4,4'-biphenol, offering significant cost reduction and supply chain reliability for engineering plastics.
Novel copper-catalyzed route for ethiprole intermediate offers high yield and mild conditions for reliable agrochemical intermediate supply chains and cost efficiency.
Patent CN110066237B reveals a mild route to N-alkynylthio phthalimides, enabling cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN112920114B reveals a novel 3-step catalytic synthesis for hydroxychloroquine sulfate, eliminating toxic phenol solvents and high-pressure risks for cost-effective manufacturing.
Patent CN117069732B details a high-purity synthesis route for benzo[c]phenanthridine alkaloids, offering supply chain reliability and cost-effective manufacturing for global pharmaceutical partners.
Patent CN107445835A enables mild synthesis of naphthalene derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101654416A details a scalable synthesis for anticancer intermediates, offering improved yields and safer processing compared to traditional nitro-reduction methods.
Patent CN112110811B details a novel Pd-catalyzed route for bilastine intermediates, offering high purity and scalable manufacturing for global supply chains.
Patent CN111269205B details a robust Pd-catalyzed method for C-aryl glycosides, offering high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Novel air-stable phosphine salt enables high-selectivity C-Cl activation. Reduces cost in pharma intermediate manufacturing via efficient palladium catalysis.
Novel Cu-catalyzed route for Flumatinib intermediate CN111763170A. Eliminates genotoxic impurities, reduces cost, ensures supply continuity for API manufacturing.
Novel patent CN103274962B offers concise route for Pralatrexate intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN106278965A reveals a copper-catalyzed method for aryl-alkyl persulfides. This breakthrough offers cost reduction in fine chemical manufacturing and high-purity intermediates.
Efficient copper-catalyzed synthesis of aryl-alkyl persulfides. Mild conditions, high yield, scalable for pharmaceutical intermediates and fine chemicals.
Advanced copper-catalyzed process for heteroaromatic BTK inhibitor intermediates ensuring high yield, mild conditions, and scalable supply chain reliability for global pharma.
Patent CN108264489B reveals a green catalytic method for quinazolines using water-soluble Ir/Ru complexes, offering significant cost reduction and supply chain reliability.
Patent CN116396299A reveals a safer 7-step synthesis for Upadacitinib intermediates, offering high purity and significant cost reduction potential for pharmaceutical manufacturers.
Patent CN115894364A reveals a green water-based photocatalytic route for alkynyl tetrahydroisoquinoline derivatives, offering significant supply chain and cost advantages.
Novel cobalt-catalyzed route offers high optical purity and scalable production for flavor and pharmaceutical intermediates.
Patent CN111393256B reveals a cost-effective Grignard coupling route for high-purity photoelectric intermediates, offering significant supply chain advantages for electronic chemical manufacturing.